Noninvasive Estimation of Blood Pressure in HeartMate 3 Patients

Alberto Pinsino; Antonia Gaudig; Francesco Castagna; Giulio M. Mondellini; Barry J. McDonnell; Eric J. Stöhr; John Cockcroft; Robert L. Kormos; Gabriel T. Sayer; Nir Uriel; Yoshifumi Naka; Koji Takeda; Melana Yuzefpolskaya; Paolo C. Colombo

doi:10.1097/mat.0000000000002012

Noninvasive Estimation of Blood Pressure in HeartMate 3 Patients

Alberto Pinsino, Antonia Gaudig, Francesco Castagna, Giulio M. Mondellini, Barry J. McDonnell, Eric J. Stöhr, John Cockcroft, Robert L. Kormos, Gabriel T. Sayer, Nir Uriel, Yoshifumi Naka, Koji Takeda, Melana Yuzefpolskaya, Paolo C. Colombo

Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid

Crynodeb

Blood pressure (BP) measurement is challenging among patients with continuous-flow left ventricular assist device (CF-LVAD) due to reduced pulse pressure (PP). Although Doppler opening BP (DOBP) is uniformly obtainable and provides an accurate measure of systolic BP (SBP), it routinely overestimates mean arterial pressure (MAP), particularly among CF-LVAD patients with higher PP. ^1,2 The success rate of traditional cuff-based automated BP (ABP) monitors ranges from 50% to 80%, and is highly dependent on PP. ^1–3 The HeartMate 3 (HM3, Abbott Labs) is the latest generation CF-LVAD with an improved pump design that resulted in significant reduction in mortality and hemocompatibility-related adverse events, ⁴ and, eventually, in a monopoly of the market. The HM3 features an artificial pulse which occurs asynchronously from the native.

Iaith wreiddiol	Saesneg
Tudalennau (o-i)	e18-e20
Cyfnodolyn	ASAIO Journal
Cyfrol	70
Rhif cyhoeddi	2
Dyddiad ar-lein cynnar	10 Gorff 2023
Dynodwyr Gwrthrych Digidol (DOIs)	https://doi.org/10.1097/mat.0000000000002012 https://doi.org/10.1097/MAT.0000000000002012
Statws	Cyhoeddwyd - 1 Chwef 2024

Mynediad at Ddogfen

Ffeiliau eraill a chysylltiadau

Dolen i’r cyhoeddiad yn Scopus

Dyfynnu hyn

Pinsino, A., Gaudig, A., Castagna, F., Mondellini, G. M., McDonnell, B. J., Stöhr, E. J., Cockcroft, J., Kormos, R. L., Sayer, G. T., Uriel, N., Naka, Y., Takeda, K., Yuzefpolskaya, M., & Colombo, P. C. (2024). Noninvasive Estimation of Blood Pressure in HeartMate 3 Patients. ASAIO Journal, 70(2), e18-e20. https://doi.org/10.1097/mat.0000000000002012, https://doi.org/10.1097/MAT.0000000000002012

@article{7d00e0481b9c4a02a72f5cc626c4f751,

title = "Noninvasive Estimation of Blood Pressure in HeartMate 3 Patients",

abstract = "Blood pressure (BP) measurement is challenging among patients with continuous-flow left ventricular assist device (CF-LVAD) due to reduced pulse pressure (PP). Although Doppler opening BP (DOBP) is uniformly obtainable and provides an accurate measure of systolic BP (SBP), it routinely overestimates mean arterial pressure (MAP), particularly among CF-LVAD patients with higher PP. 1,2 The success rate of traditional cuff-based automated BP (ABP) monitors ranges from 50% to 80%, and is highly dependent on PP. 1–3 The HeartMate 3 (HM3, Abbott Labs) is the latest generation CF-LVAD with an improved pump design that resulted in significant reduction in mortality and hemocompatibility-related adverse events, 4 and, eventually, in a monopoly of the market. The HM3 features an artificial pulse which occurs asynchronously from the native.",

keywords = "Doppler, automated blood pressure monitor, blood pressure, left ventricular assist device",

author = "Alberto Pinsino and Antonia Gaudig and Francesco Castagna and Mondellini, {Giulio M.} and McDonnell, {Barry J.} and St{\"o}hr, {Eric J.} and John Cockcroft and Kormos, {Robert L.} and Sayer, {Gabriel T.} and Nir Uriel and Yoshifumi Naka and Koji Takeda and Melana Yuzefpolskaya and Colombo, {Paolo C.}",

year = "2024",

month = feb,

day = "1",

doi = "10.1097/mat.0000000000002012",

language = "English",

volume = "70",

pages = "e18--e20",

journal = "ASAIO Journal",

issn = "1058-2916",

publisher = "Ovid Technologies (Wolters Kluwer Health)",

number = "2",

}

Pinsino, A, Gaudig, A, Castagna, F, Mondellini, GM, McDonnell, BJ, Stöhr, EJ, Cockcroft, J, Kormos, RL, Sayer, GT, Uriel, N, Naka, Y, Takeda, K, Yuzefpolskaya, M & Colombo, PC 2024, 'Noninvasive Estimation of Blood Pressure in HeartMate 3 Patients', ASAIO Journal, cyfrol. 70, rhif 2, tt. e18-e20. https://doi.org/10.1097/mat.0000000000002012, https://doi.org/10.1097/MAT.0000000000002012

TY - JOUR

T1 - Noninvasive Estimation of Blood Pressure in HeartMate 3 Patients

AU - Pinsino, Alberto

AU - Gaudig, Antonia

AU - Castagna, Francesco

AU - Mondellini, Giulio M.

AU - McDonnell, Barry J.

AU - Stöhr, Eric J.

AU - Cockcroft, John

AU - Kormos, Robert L.

AU - Sayer, Gabriel T.

AU - Uriel, Nir

AU - Naka, Yoshifumi

AU - Takeda, Koji

AU - Yuzefpolskaya, Melana

AU - Colombo, Paolo C.

PY - 2024/2/1

Y1 - 2024/2/1

N2 - Blood pressure (BP) measurement is challenging among patients with continuous-flow left ventricular assist device (CF-LVAD) due to reduced pulse pressure (PP). Although Doppler opening BP (DOBP) is uniformly obtainable and provides an accurate measure of systolic BP (SBP), it routinely overestimates mean arterial pressure (MAP), particularly among CF-LVAD patients with higher PP. 1,2 The success rate of traditional cuff-based automated BP (ABP) monitors ranges from 50% to 80%, and is highly dependent on PP. 1–3 The HeartMate 3 (HM3, Abbott Labs) is the latest generation CF-LVAD with an improved pump design that resulted in significant reduction in mortality and hemocompatibility-related adverse events, 4 and, eventually, in a monopoly of the market. The HM3 features an artificial pulse which occurs asynchronously from the native.

AB - Blood pressure (BP) measurement is challenging among patients with continuous-flow left ventricular assist device (CF-LVAD) due to reduced pulse pressure (PP). Although Doppler opening BP (DOBP) is uniformly obtainable and provides an accurate measure of systolic BP (SBP), it routinely overestimates mean arterial pressure (MAP), particularly among CF-LVAD patients with higher PP. 1,2 The success rate of traditional cuff-based automated BP (ABP) monitors ranges from 50% to 80%, and is highly dependent on PP. 1–3 The HeartMate 3 (HM3, Abbott Labs) is the latest generation CF-LVAD with an improved pump design that resulted in significant reduction in mortality and hemocompatibility-related adverse events, 4 and, eventually, in a monopoly of the market. The HM3 features an artificial pulse which occurs asynchronously from the native.

KW - Doppler

KW - automated blood pressure monitor

KW - blood pressure

KW - left ventricular assist device

UR - http://www.scopus.com/inward/record.url?scp=85184345438&partnerID=8YFLogxK

U2 - 10.1097/mat.0000000000002012

DO - 10.1097/mat.0000000000002012

M3 - Article

C2 - 37429021

SN - 1058-2916

VL - 70

SP - e18-e20

JO - ASAIO Journal

JF - ASAIO Journal

IS - 2

ER -